Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here.
COVID-19
Evidence-based recommendations
Harm reduction
Outdoor transmission
Pandemic
Pandemic preparedness
Policy
Public health
SARS-CoV-2
School closure
Vaccines
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
13 11 2021
13 11 2021
Historique:
received:
28
06
2021
accepted:
22
10
2021
entrez:
14
11
2021
pubmed:
15
11
2021
medline:
18
11
2021
Statut:
epublish
Résumé
Strategies to control coronavirus 2019 disease (COVID-19) have often been based on preliminary and limited data and have tended to be slow to evolve as new evidence emerges. Yet knowledge about COVID-19 has grown exponentially, and the expanding rollout of vaccines presents further opportunity to reassess the response to the pandemic more broadly. We review the latest evidence concerning 10 key COVID-19 policy and strategic areas, specifically addressing: 1) the expansion of equitable vaccine distribution, 2) the need to ease restrictions as hospitalization and mortality rates eventually fall, 3) the advantages of emphasizing educational and harm reduction approaches over coercive and punitive measures, 4) the need to encourage outdoor activities, 5) the imperative to reopen schools, 6) the far-reaching and long-term economic and psychosocial consequences of sustained lockdowns, 7) the excessive focus on surface disinfection and other ineffective measures, 8) the importance of reassessing testing policies and practices, 9) the need for increasing access to outpatient therapies and prophylactics, and 10) the necessity to better prepare for future pandemics. While remarkably effective vaccines have engendered great hope, some widely held assumptions underlying current policy approaches call for an evidence-based reassessment. COVID-19 will require ongoing mitigation for the foreseeable future as it transforms from a pandemic into an endemic infection, but maintaining a constant state of emergency is not viable. A more realistic public health approach is to adjust current mitigation goals to be more data-driven and to minimize unintended harms associated with unfocused or ineffective control efforts. Based on the latest evidence, we therefore present recommendations for refining 10 key policy areas, and for applying lessons learned from COVID-19 to prevent and prepare for future pandemics.
Sections du résumé
BACKGROUND
Strategies to control coronavirus 2019 disease (COVID-19) have often been based on preliminary and limited data and have tended to be slow to evolve as new evidence emerges. Yet knowledge about COVID-19 has grown exponentially, and the expanding rollout of vaccines presents further opportunity to reassess the response to the pandemic more broadly.
MAIN TEXT
We review the latest evidence concerning 10 key COVID-19 policy and strategic areas, specifically addressing: 1) the expansion of equitable vaccine distribution, 2) the need to ease restrictions as hospitalization and mortality rates eventually fall, 3) the advantages of emphasizing educational and harm reduction approaches over coercive and punitive measures, 4) the need to encourage outdoor activities, 5) the imperative to reopen schools, 6) the far-reaching and long-term economic and psychosocial consequences of sustained lockdowns, 7) the excessive focus on surface disinfection and other ineffective measures, 8) the importance of reassessing testing policies and practices, 9) the need for increasing access to outpatient therapies and prophylactics, and 10) the necessity to better prepare for future pandemics.
CONCLUSIONS
While remarkably effective vaccines have engendered great hope, some widely held assumptions underlying current policy approaches call for an evidence-based reassessment. COVID-19 will require ongoing mitigation for the foreseeable future as it transforms from a pandemic into an endemic infection, but maintaining a constant state of emergency is not viable. A more realistic public health approach is to adjust current mitigation goals to be more data-driven and to minimize unintended harms associated with unfocused or ineffective control efforts. Based on the latest evidence, we therefore present recommendations for refining 10 key policy areas, and for applying lessons learned from COVID-19 to prevent and prepare for future pandemics.
Identifiants
pubmed: 34774012
doi: 10.1186/s12889-021-12082-z
pii: 10.1186/s12889-021-12082-z
pmc: PMC8590121
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2084Informations de copyright
© 2021. The Author(s).
Références
N Engl J Med. 2020 Nov 19;383(21):2092
pubmed: 33095523
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):136-140
pubmed: 33507890
PLoS Med. 2020 Jun 30;17(6):e1003266
pubmed: 32603323
Science. 2021 Jun 4;372(6546):1092-1097
pubmed: 33927057
JAMA Intern Med. 2021 Oct 1;181(10):1407-1408
pubmed: 34048531
MMWR Morb Mortal Wkly Rep. 2021 Sep 03;70(35):1214-1219
pubmed: 34473683
BMJ. 2021 Sep 13;374:n2101
pubmed: 34518194
N Engl J Med. 2021 Feb 18;384(7):669-671
pubmed: 33406327
Nat Med. 2021 Aug;27(8):1370-1378
pubmed: 34108716
Cell. 2021 Feb 18;184(4):861-880
pubmed: 33497610
Allergy Asthma Clin Immunol. 2021 Jan 6;17(1):5
pubmed: 33407838
Front Immunol. 2021 Apr 12;12:669339
pubmed: 33912196
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166
pubmed: 34437519
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
Science. 2021 Jan 8;371(6525):126-127
pubmed: 33414210
BMJ. 2020 Nov 2;371:m4074
pubmed: 33139247
Front Microbiol. 2020 Dec 15;11:590683
pubmed: 33384670
JAMA. 2021 Apr 13;325(14):1467-1469
pubmed: 33646292
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
Science. 2020 Mar 13;367(6483):1177-1178
pubmed: 32165563
BMC Infect Dis. 2021 Jul 27;21(1):710
pubmed: 34315427
Lancet. 2021 Mar 20;397(10279):1057-1058
pubmed: 33640038
Nat Med. 2021 Sep;27(9):1614-1621
pubmed: 34244681
Lancet Psychiatry. 2020 Jun;7(6):468-471
pubmed: 32330430
MMWR Morb Mortal Wkly Rep. 2021 Apr 02;70(13):495-500
pubmed: 33793460
Med (N Y). 2021 Aug 13;2(8):979-992.e8
pubmed: 34223401
Cell. 2021 Mar 4;184(5):1127-1132
pubmed: 33581746
Cell Rep Med. 2021 Jul 20;2(7):100355
pubmed: 34230917
Clin Infect Dis. 2021 Oct 15;:
pubmed: 34651164
Nat Commun. 2021 Aug 17;12(1):5061
pubmed: 34404775
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):
pubmed: 33574041
Clin Infect Dis. 2021 May 27;:
pubmed: 34043763
J Infect Public Health. 2021 Apr;14(4):461-467
pubmed: 33743366
Labour Econ. 2021 Jun;70:101993
pubmed: 34754143
Prev Chronic Dis. 2020 Jul 09;17:E59
pubmed: 32644919
J Hosp Infect. 2020 Apr;104(4):451
pubmed: 32092368
Immunity. 2020 Nov 17;53(5):925-933.e4
pubmed: 33129373
Nature. 2019 Nov;575(7781):130-136
pubmed: 31695207
Nat Med. 2021 Jun;27(6):981-984
pubmed: 33795870
Ann Epidemiol. 2021 Feb;54:21-26
pubmed: 33242596
Lancet Glob Health. 2021 Apr;9(4):e393-e394
pubmed: 33581050
Clin Microbiol Rev. 2020 Oct 28;34(1):
pubmed: 33115724
Euro Surveill. 2020 Sep;25(36):
pubmed: 32914746
BMJ. 2021 May 10;373:n1182
pubmed: 33972288
Int Arch Allergy Immunol. 2020;181(9):680-688
pubmed: 32516795
JAMA. 2021 May 25;325(20):2112-2113
pubmed: 33861316
N Engl J Med. 2021 Feb 11;384(6):533-540
pubmed: 33369366
Lancet. 2021 May 8;397(10286):1725-1735
pubmed: 33901423
Aging (Albany NY). 2020 Jul 13;12(13):12493-12503
pubmed: 32658868
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1150-1155
pubmed: 34437517
Wellcome Open Res. 2020 May 1;5:83
pubmed: 32656368
Nature. 2021 Jul 30;:
pubmed: 34331049
Lancet. 2021 Apr 17;397(10283):1459-1469
pubmed: 33844963
Science. 2021 Mar 19;371(6535):1184
pubmed: 33737463
Obes Rev. 2020 Oct;21(10):e13095
pubmed: 32686331
Cell. 2021 Nov 11;184(23):5699-5714.e11
pubmed: 34735795
MMWR Morb Mortal Wkly Rep. 2021 May 28;70(21):779-784
pubmed: 34043610
MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):705-709
pubmed: 32525852
Ann Intern Med. 2021 Mar;174(3):335-343
pubmed: 33205991
Lancet Microbe. 2021 Jan;2(1):e13-e22
pubmed: 33521734
JAMA. 2021 Mar 2;325(9):823-824
pubmed: 33497433
MMWR Morb Mortal Wkly Rep. 2020 Apr 24;69(16):496-498
pubmed: 32324720
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Immun Ageing. 2021 Aug 20;18(1):34
pubmed: 34416887
MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1860-1867
pubmed: 33301434
Int J Environ Res Public Health. 2019 Nov 21;16(23):
pubmed: 31766548
Science. 2008 May 9;320(5877):749-50
pubmed: 18467575
BMJ. 2021 Jun 4;373:n1445
pubmed: 34088699
Nat Rev Drug Discov. 2021 Apr;20(4):254-255
pubmed: 33633370
Nat Rev Immunol. 2021 Nov;21(11):687-688
pubmed: 34497383
Cad Saude Publica. 2020 Apr 30;36(4):e00074420
pubmed: 32374808
BMJ. 2020 Apr 27;369:m1557
pubmed: 32341002
Int J Infect Dis. 2021 Jan;102:247-253
pubmed: 33129965
Nat Hum Behav. 2021 Jul;5(7):947-953
pubmed: 33972767
MMWR Morb Mortal Wkly Rep. 2021 Jul 27;70(30):1044-1047
pubmed: 34324480
JAMA Netw Open. 2021 Mar 1;4(3):e212536
pubmed: 33749764
Euro Surveill. 2021 Sep;26(35):
pubmed: 34477054
Int Arch Allergy Immunol. 2021;182(1):76-82
pubmed: 32961539
J Travel Med. 2021 Jun 1;28(4):
pubmed: 34008004
Glob Health Sci Pract. 2020 Jun 30;8(2):136-143
pubmed: 32522765
Pediatrics. 2021 Apr;147(4):
pubmed: 33419869
PLoS Biol. 2020 Nov 12;18(11):e3000897
pubmed: 33180773
Clin Infect Dis. 2021 Sep 15;73(6):e1365-e1367
pubmed: 33768222
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
PLoS One. 2020 Aug 26;15(8):e0238215
pubmed: 32845926
Sci Transl Med. 2021 Jun 30;13(600):
pubmed: 34103407
Clin Infect Dis. 2021 Sep 15;73(6):e1261-e1269
pubmed: 33709135
JAMA Netw Open. 2021 Sep 1;4(9):e2124092
pubmed: 34477850
Indoor Air. 2021 May;31(3):639-645
pubmed: 33131151
Lancet Respir Med. 2020 May;8(5):436-438
pubmed: 32251625
Minerva Pediatr. 2020 Jun;72(3):226-235
pubmed: 32613821
Trop Med Health. 2020 Sep 14;48:79
pubmed: 32939152
Expert Rev Vaccines. 2021 Oct;20(10):1201-1209
pubmed: 34488546
J Infect. 2020 Sep;81(3):357-371
pubmed: 32615199
Expert Rev Vaccines. 2021 Aug;20(8):1013-1025
pubmed: 34180347
Disaster Med Public Health Prep. 2021 Aug;15(4):e5-e7
pubmed: 32907666
Lancet. 2021 Mar 27;397(10280):1204-1212
pubmed: 33743221
Glob Health Sci Pract. 2020 Jun 30;8(2):155-165
pubmed: 32554522
Nat Rev Microbiol. 2021 Aug;19(8):528-545
pubmed: 33753932
Nat Med. 2021 May;27(5):790-792
pubmed: 33782619
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
Lancet Infect Dis. 2021 May;21(5):e112
pubmed: 33007224
N Engl J Med. 2021 Aug 12;385(7):585-594
pubmed: 34289274
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1167-1169
pubmed: 34437521
Lancet Infect Dis. 2020 Aug;20(8):892-893
pubmed: 32628907
J Paediatr Child Health. 2020 Jul;56(7):1013-1017
pubmed: 32619327
BMJ. 2021 Mar 23;372:n771
pubmed: 33757984
Wien Klin Wochenschr. 2021 Apr;133(7-8):331-335
pubmed: 33095321
Open Forum Infect Dis. 2020 Dec 14;8(1):ofaa603
pubmed: 33506067
Nature. 2021 Feb;590(7844):26-28
pubmed: 33514939
J Clin Microbiol. 2020 Oct 21;58(11):
pubmed: 32817231
Nat Hum Behav. 2020 Dec;4(12):1303-1312
pubmed: 33199859
Sci Adv. 2021 Jan 1;7(1):
pubmed: 33277325
Clin Infect Dis. 2021 Nov 16;73(10):1871-1878
pubmed: 33704422
Obesity (Silver Spring). 2020 Jun;28(6):1008-1009
pubmed: 32227671
Nature. 2021 Feb;590(7846):374-375
pubmed: 33580217
BMJ. 2021 May 13;373:n1088
pubmed: 33985964
Lancet. 2021 Mar 27;397(10280):1178-1181
pubmed: 33640037
Am J Public Health. 2004 Mar;94(3):400-5
pubmed: 14998803
J Intern Med. 2021 Apr;289(4):450-462
pubmed: 33020988
Lancet. 2021 Apr 10;397(10282):1351-1362
pubmed: 33798499
BMJ. 2020 Dec 22;371:m4907
pubmed: 33561814
Lancet. 2021 May 15;397(10287):1819-1829
pubmed: 33964222
Clin Infect Dis. 2021 Oct 5;73(7):1320-1321
pubmed: 33502467
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1070-1073
pubmed: 32790662
Lancet. 2020 Apr 25;395(10233):1331-1332
pubmed: 32334692
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
J Asthma. 2021 Apr 1;:1-14
pubmed: 33556287
Clin Infect Dis. 2020 Dec 03;:
pubmed: 33270107
Lancet. 2017 Dec 9;390(10112):2602-2604
pubmed: 28622953
Lancet. 2021 Mar 13;397(10278):952-954
pubmed: 33581803
Infect Control Hosp Epidemiol. 2021 Sep 06;:1-7
pubmed: 34486511
Clin Infect Dis. 2021 Jul 30;73(Suppl 2):S170-S176
pubmed: 32964919
Hum Vaccin Immunother. 2021 Jul 22;:1-4
pubmed: 34292128
Lancet. 2021 Mar 6;397(10277):875-877
pubmed: 33610193
Ann Intern Med. 2021 Jan;174(1):69-79
pubmed: 32941052